» Articles » PMID: 10971819

How Can the Cellular Immune Response Control Hepatitis B Virus Replication?

Overview
Journal J Viral Hepat
Specialty Gastroenterology
Date 2000 Sep 6
PMID 10971819
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

In this review we focus on aspects of the virus-specific cellular immune response, although we should point out that all the components of the innate and adaptive immune response are likely to play a role in successful control of hepatitis B virus (HBV) infection. We concentrate particularly on the relevance of the polyclonality and multispecificity of the HBV-specific cytotoxic T cell response to its antiviral activity. In this context, we discuss the possible role of viral escape mutations and highlight evidence from other models of the benefit of multispecificity in antiviral responses. We stress the contribution of CD4 help for effective CD8 responses and raise the possibility that HBV may produce factors inhibiting the antiviral response.

Citing Articles

Polymorphisms in CISH gene are associated with persistent hepatitis B virus infection in Han Chinese population.

Hu Z, Yang J, Wu Y, Xiong G, Wang Y, Yang J PLoS One. 2014; 9(6):e100826.

PMID: 24964072 PMC: 4071005. DOI: 10.1371/journal.pone.0100826.


Clinical impact of hepatitis B and C virus envelope glycoproteins.

Jeulin H, Velay A, Murray J, Schvoerer E World J Gastroenterol. 2013; 19(5):654-64.

PMID: 23429668 PMC: 3574591. DOI: 10.3748/wjg.v19.i5.654.


Sustained and transient oscillations and chaos induced by delayed antiviral immune response in an immunosuppressive infection model.

Shu H, Wang L, Watmough J J Math Biol. 2013; 68(1-2):477-503.

PMID: 23306425 DOI: 10.1007/s00285-012-0639-1.


Association of markers of chronic viral hepatitis and blood mercury levels in US reproductive-age women from NHANES 2001-2008: a cross-sectional study.

Sheehan M, Burke T, Breysse P, Navas-Acien A, McGready J, Fox M Environ Health. 2012; 11:62.

PMID: 22970929 PMC: 3511886. DOI: 10.1186/1476-069X-11-62.


Immunomodulation therapy in children with chronic hepatitis B.

Karaoglan M, Demirci F, Coskun Y, Karaoglan I, Bayraktaroglu Z, Okan V J Natl Med Assoc. 2006; 98(2):143-7.

PMID: 16708498 PMC: 2595034.